While histological information is crucial for treatment decisions in solid cancers, including GC, our findings highlight the importance of assessing 1C metabolism-related genes in intestinal-type GC patients with high CD44 expression (Fig. 7) [73, 74]. This evidence concerns the gene CD44 and gastric cancer.